Delivery Order SPE2DB22D1002-SPE2DB25FLCY0
- Not listed
- The Defense Logistics Agency awarded a $3,931.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with performance in Conshohocken, Pennsylvania and completion scheduled for June 2, 2025. This non-set-aside award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value extending through December 2026. As a major...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $39,270.67. This non-competitive, firm fixed-price delivery order is scheduled for completion by June 3, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,744.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 10, 2025. This competitive award, issued on September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains operations as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $18,393.96 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $33,624.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters, where it maintains significant pharmaceutical distribution operations supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,399.91 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 27, 2025, with performance expected to conclude by August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $17,178.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60 count) on July 21, 2025, with a completion date of July 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,124.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a competitively awarded pharmaceutical supply transaction to support federal medical procurement needs. The award leverages AmerisourceBergen's established relationship as a critical vendor within the federal healthcare supply chain, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $3,961.54 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's capability to compete in open...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLCY0Delivery Order
The Defense Logistics Agency awarded a $3,676.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product supporting federal medical procurement needs. This non-competitive delivery order, issued on June 2, 2025 with completion targeted for June 3, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a comprehensive global pharmaceutical support vehicle, this prime contract enables the company to supply medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's contract portfolio demonstrates its role as a critical pharmaceutical distributor within the federal medical supply chain, consistently delivering both brand-name and generic medications through competitively awarded arrangements with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 6/2/25 |